www.fdanews.com/articles/61436-thermogenesis-corp-signs-agreement-with-biomet-biologics-inc-to-produce-intra-operative-autologous-fibrin-sealant
THERMOGENESIS CORP. SIGNS AGREEMENT WITH BIOMET BIOLOGICS, INC. TO PRODUCE INTRA-OPERATIVE AUTOLOGOUS FIBRIN SEALANT
August 3, 2006
ThermoGenesis Corp. announced that the Company entered into a development, license and supply agreement with Biomet Biologics, Inc., a wholly owned subsidiary of Biomet, Inc. Biomet Biologics plans to combine ThermoGenesis' protein harvesting technology with its currently offered and future autologous therapies to manufacture autologous fibrin sealant in a peri-operative setting. The product will feature
a fibrinogen harvesting disposable in combination with Biomet Biologics' Clotalyst
System that can produce fibrin sealant from a patient's own blood in less than
30 minutes. Fibrin sealant is an adhesive gel used by surgeons to stop bleeding
and bond tissue.
Yahoo
News